Device type · NBW
System, Test, Blood Glucose, Over The Counter
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NBW
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
152
510(k), De Novo and PMA
Adverse event reports
5,083
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Test, Blood Glucose, Over The Counter
- Product code
- NBW
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
- FDA record
- Classification database entry for NBW
Latest FDA decisions
The 8 newest of 152 since 2015.
K260738 · Decided Oct 30, 2026 · 238 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K261293 · Decided Oct 23, 2026 · 186 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
Vivachek Biotech (Hangzhou) Co., Ltd.
K260687 · Decided Oct 9, 2026 · 220 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K260689 · Decided Oct 2, 2026 · 213 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K260545 · Decided Aug 27, 2026 · 190 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K262116 · Decided Jul 23, 2026 · 30 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K250085 · Decided Oct 10, 2025 · 270 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
Guangdong Transtek Medical Electronics Co., Ltd.
K243060 · Decided Jan 30, 2025 · 125 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
Reports received
5,083
Received Nov 1, 2025 to Nov 19, 2026. Includes 28 of another or unstated type.
Malfunction reports
4,825
95% of reports
Injury reports
226
4.4% of reports
Death reports
4
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 543 | 47 | 1 | 0 |
| Jan 24 | 604 | 53 | 0 | 1 |
| Feb 24 | 491 | 62 | 0 | 0 |
| Mar 24 | 415 | 38 | 0 | 0 |
| Apr 24 | 590 | 67 | 0 | 0 |
| May 24 | 504 | 40 | 0 | 0 |
| Jun 24 | 331 | 43 | 0 | 0 |
| Jul 24 | 525 | 41 | 0 | 0 |
| Aug 24 | 424 | 48 | 0 | 1 |
| Sep 24 | 439 | 29 | 0 | 1 |
| Oct 24 | 459 | 48 | 0 | 0 |
| Nov 24 | 441 | 38 | 0 | 0 |
| Dec 24 | 459 | 28 | 0 | 0 |
| Jan 25 | 420 | 32 | 0 | 0 |
| Feb 25 | 411 | 19 | 0 | 0 |
| Mar 25 | 377 | 34 | 0 | 0 |
| Apr 25 | 343 | 26 | 0 | 0 |
| May 25 | 388 | 15 | 1 | 0 |
| Jun 25 | 361 | 28 | 0 | 0 |
| Jul 25 | 359 | 16 | 0 | 1 |
| Aug 25 | 385 | 30 | 0 | 0 |
| Sep 25 | 381 | 31 | 1 | 0 |
| Oct 25 | 394 | 34 | 0 | 0 |
| Nov 25 | 331 | 30 | 0 | 0 |
| Dec 25 | 343 | 20 | 0 | 0 |
| Jan 26 | 473 | 18 | 0 | 0 |
| Feb 26 | 352 | 17 | 1 | 0 |
| Mar 26 | 267 | 30 | 1 | 0 |
| Apr 26 | 398 | 21 | 1 | 0 |
| May 26 | 383 | 11 | 0 | 1 |
| Jun 26 | 363 | 19 | 0 | 1 |
| Jul 26 | 402 | 23 | 1 | 6 |
| Aug 26 | 383 | 10 | 0 | 6 |
| Sep 26 | 630 | 18 | 0 | 8 |
| Oct 26 | 500 | 9 | 0 | 6 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Failure to Power Up3,492
- Incorrect, Inadequate or Imprecise Result or Readings706
- High Test Results154
- High Readings136
- Low Readings98
- Computer Software Problem94
- Image Display Error/Artifact69
- Low Test Results68
- Unable to Obtain Readings58
- Display or Visual Feedback Problem53
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions4,728
- Hyperglycemia110
- Hypoglycemia61
- Dizziness58
- Insufficient Information54
- Fatigue35
- Loss of consciousness24
- Headache22
- Shaking/Tremors21
- Nausea20
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1545-2026 · Started Feb 6, 2026 · Posted by FDA Mar 12, 2026
Reason given: The system labeling (user manual and online labeling) did not provide adequate directions for lay users to act on the E-5 error code. The error code description and recommended actions for the E-5 error code in the labeling do not: (a) clearly emphasize that an E-5 error code could represent a very high blood glucose...
Cause as FDA categorized it: Software design
Z-1546-2026 · Started Feb 6, 2026 · Posted by FDA Mar 12, 2026
Reason given: The system labeling (user manual and online labeling) did not provide adequate directions for lay users to act on the E-5 error code. The error code description and recommended actions for the E-5 error code in the labeling do not: (a) clearly emphasize that an E-5 error code could represent a very high blood glucose...
Cause as FDA categorized it: Software design
Z-1547-2026 · Started Feb 6, 2026 · Posted by FDA Mar 12, 2026
Reason given: The system labeling (user manual and online labeling) did not provide adequate directions for lay users to act on the E-5 error code. The error code description and recommended actions for the E-5 error code in the labeling do not: (a) clearly emphasize that an E-5 error code could represent a very high blood glucose...
Cause as FDA categorized it: Software design
Z-1548-2026 · Started Feb 6, 2026 · Posted by FDA Mar 12, 2026
Reason given: The system labeling (user manual and online labeling) did not provide adequate directions for lay users to act on the E-5 error code. The error code description and recommended actions for the E-5 error code in the labeling do not: (a) clearly emphasize that an E-5 error code could represent a very high blood glucose...
Cause as FDA categorized it: Software design
- Good Neighbor Pharmacy, TRUE METRIX Self Monitoring Blood Glucose Meter. Model/Catalog Number: RE4011-01.Open, Classified
Z-0413-2026 · Started Oct 7, 2025 · Posted by FDA Oct 30, 2025
Reason given: Manufacturing defect causing LCD display issues with missing or partial segments (ghosting) that can result in misreading glucose values, potentially leading to inappropriate treatment decisions for diabetes management.
Cause as FDA categorized it: Device Design
Z-1270-2025 · Started Jan 30, 2025 · Posted by FDA Mar 5, 2025
Reason given: Telcare, LLC has received customer complaints related to battery expansion/swelling for its Philips Connected Blood Glucose Meter (i.e., BGM 4 brand name) Monitoring System.. The issue was identified by post market surveillance data (customer complaints) - events of battery expansion/swelling and associated symptoms,...
Cause as FDA categorized it: Software design
Z-2174-2024 · Started May 13, 2024 · Posted by FDA Jun 21, 2024
Reason given: The reason for recall is the meters may show an incorrect measurement unit (mmol/L rather than mg/dL) and may result in the wrong unit of measure. Which may subsequently cause an error in interpreting a result as approximately 18 times lower that the actual blood glucose. Potential immediate health consequences of the...
Cause as FDA categorized it: Reprocessing Controls
- Contour next GEN Blood Glucose Monitoring SystemOpen, Classified
Ascensia Diabetes Care US, Inc.
Z-2211-2023 · Started May 19, 2023 · Posted by FDA Jul 20, 2023
Reason given: Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display...
Cause as FDA categorized it: Process control
Showing the 8 newest of 137 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.